Caroverin and Inner Ear Diseases

Summary

This trial is a randomized, double blind, placebo controlled study on patients suffering from inner ear diseases with tinnitus as a principal symptom. The study will investigate the transtympanic treatment with a 1,5 % caroverine solution. Each patient will undergo treatment for 2 cycles of 48 hours each.

Timeline

Start

2011-01

Primary completion

2015-08

Completion

—

Outcome

Outcome not reported

Stopped: “due to less patient the study was suspended”

Drugs

Indications